BiotechTube

CMX001

Phase 2Withdrawn
0 watching 0 views this week⚡ Active
49
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Ebola Virus

Conditions

Ebola Virus

Trial Timeline

Oct 1, 2014 → Jan 1, 2015

NCT ID
NCT02271347

About CMX001

CMX001 is a phase 2 stage product being developed by Jazz Pharmaceuticals for Ebola Virus. The current trial status is withdrawn. This product is registered under clinical trial identifier NCT02271347. Target conditions include Ebola Virus.

Hype Score Breakdown

Clinical
17
Activity
12
Company
7
Novelty
5
Community
5

Clinical Trials (4)

NCT IDPhaseStatus
NCT02271347Phase 2Withdrawn
NCT02167685Pre-clinicalTerminated
NCT05391724Phase 1Completed
NCT00780182Phase 1Completed

Competing Products

20 competing products in Ebola Virus

See all competitors
ProductCompanyStageHype Score
Ad26.ZEBOV vaccineJohnson & JohnsonPhase 2
52
rVSVΔG-ZEBOV-GP, V920 + Chikenpox or Varicella vaccine (VARILRIX)MerckPhase 1/2
41
V920 VaccineMerckPhase 1
33
Recombinant Vesicular Stomatitis Vaccine for Ebola (rVSV∆G-ZEBOV-GP)MerckPhase 2
52
rVSVDG-ZEBOV-GP Ebola Virus Vaccine (ERVEBO)MerckApproved
85
V920 (rVSVΔG-ZEBOV-GP) Ebola Virus VaccineMerckPhase 2
52
V920MerckPhase 1
33
V920 Consistency Lot A + V920 Consistency Lot B + V920 Consistency Lot C + V920 High-dose Lot + Placebo to V920MerckPhase 3
77
BioNTech - Pfizer COVID-19 vaccine + 1mL saline solution + rVSV∆G-ZEBOV-GPMerckApproved
85
V920MerckPhase 1
33
GS-5734Gilead SciencesPhase 2
51
REGN3470-3471-3479Regeneron PharmaceuticalsPre-clinical
22
Ervebo + InmazebRegeneron PharmaceuticalsPhase 2
51
AVI-7537United TherapeuticsPhase 1
30
Placebo + AVI-6002United TherapeuticsPhase 1
30
Ad26.ZEBOV + MVA-BN-FiloBavarian NordicPhase 3
74
BrincidofovirJazz PharmaceuticalsPhase 2
49
cAd3-Marburg + cAd3-EBO-SICON plc.Phase 1
30
Base Dose EBOV GP Vaccine + 2x Base Dose EBOV GP Vaccine + 4x Base Dose EBOV GP Vaccine + 8x Base Dose EBOV GP Vaccine + Placebo + Matrix-M AdjuvantNovavaxPhase 1
28
TKM-100802 for Injection + PlaceboArbutus BiopharmaPhase 1
28

Other Products from Jazz Pharmaceuticals

Sativex + PlaceboApproved
82
Sodium OxybateApproved
82
JZP258Approved
82
Solriamfetol + PlaceboApproved
82
Placebo + Sodium OxybateApproved
82